Independence Contract Drilling, Inc.

ICD plays a significant role within the Energy sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICD stands at 8.9M. In comparison, NE has a market cap of 7.8B. Regarding current trading prices, ICD is priced at $0.59, while NE trades at $48.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICD currently has a P/E ratio of -0.14, whereas NE's P/E ratio is 36.26. In terms of profitability, ICD's ROE is -0.19%, compared to NE's ROE of +0.05%. Regarding short-term risk, ICD is more volatile compared to NE. This indicates potentially higher risk in terms of short-term price fluctuations for ICD.Check NE's competition here

ICD plays a significant role within the Energy sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICD stands at 8.9M. In comparison, RIG has a market cap of 5.5B. Regarding current trading prices, ICD is priced at $0.59, while RIG trades at $6.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICD currently has a P/E ratio of -0.14, whereas RIG's P/E ratio is -1.99. In terms of profitability, ICD's ROE is -0.19%, compared to RIG's ROE of -0.33%. Regarding short-term risk, ICD is more volatile compared to RIG. This indicates potentially higher risk in terms of short-term price fluctuations for ICD.Check RIG's competition here

ICD plays a significant role within the Energy sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICD stands at 8.9M. In comparison, PTEN has a market cap of 4.2B. Regarding current trading prices, ICD is priced at $0.59, while PTEN trades at $11.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICD currently has a P/E ratio of -0.14, whereas PTEN's P/E ratio is -46.42. In terms of profitability, ICD's ROE is -0.19%, compared to PTEN's ROE of -0.04%. Regarding short-term risk, ICD is less volatile compared to PTEN. This indicates potentially lower risk in terms of short-term price fluctuations for ICD.Check PTEN's competition here

ICD plays a significant role within the Energy sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICD stands at 8.9M. In comparison, HP has a market cap of 3.8B. Regarding current trading prices, ICD is priced at $0.59, while HP trades at $37.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICD currently has a P/E ratio of -0.14, whereas HP's P/E ratio is -11.78. In terms of profitability, ICD's ROE is -0.19%, compared to HP's ROE of -0.11%. Regarding short-term risk, ICD is more volatile compared to HP. This indicates potentially higher risk in terms of short-term price fluctuations for ICD.Check HP's competition here

ICD plays a significant role within the Energy sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICD stands at 8.9M. In comparison, SDRL has a market cap of 3B. Regarding current trading prices, ICD is priced at $0.59, while SDRL trades at $47.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICD currently has a P/E ratio of -0.14, whereas SDRL's P/E ratio is -38.49. In terms of profitability, ICD's ROE is -0.19%, compared to SDRL's ROE of -0.03%. Regarding short-term risk, ICD is more volatile compared to SDRL. This indicates potentially higher risk in terms of short-term price fluctuations for ICD.Check SDRL's competition here

ICD plays a significant role within the Energy sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICD stands at 8.9M. In comparison, DO has a market cap of 1.4B. Regarding current trading prices, ICD is priced at $0.59, while DO trades at $13.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICD currently has a P/E ratio of -0.14, whereas DO's P/E ratio is -5.24. In terms of profitability, ICD's ROE is -0.19%, compared to DO's ROE of -0.07%. Regarding short-term risk, ICD is more volatile compared to DO. This indicates potentially higher risk in terms of short-term price fluctuations for ICD.Check DO's competition here

ICD plays a significant role within the Energy sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICD stands at 8.9M. In comparison, SOC has a market cap of 1.4B. Regarding current trading prices, ICD is priced at $0.59, while SOC trades at $14.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICD currently has a P/E ratio of -0.14, whereas SOC's P/E ratio is -3.41. In terms of profitability, ICD's ROE is -0.19%, compared to SOC's ROE of -1.02%. Regarding short-term risk, ICD is more volatile compared to SOC. This indicates potentially higher risk in terms of short-term price fluctuations for ICD.Check SOC's competition here

ICD plays a significant role within the Energy sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICD stands at 8.9M. In comparison, BORR has a market cap of 1.4B. Regarding current trading prices, ICD is priced at $0.59, while BORR trades at $5.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICD currently has a P/E ratio of -0.14, whereas BORR's P/E ratio is 32.74. In terms of profitability, ICD's ROE is -0.19%, compared to BORR's ROE of +0.04%. Regarding short-term risk, ICD is more volatile compared to BORR. This indicates potentially higher risk in terms of short-term price fluctuations for ICD.Check BORR's competition here

ICD plays a significant role within the Energy sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICD stands at 8.9M. In comparison, NBR has a market cap of 1.3B. Regarding current trading prices, ICD is priced at $0.59, while NBR trades at $88.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICD currently has a P/E ratio of -0.14, whereas NBR's P/E ratio is 5.09. In terms of profitability, ICD's ROE is -0.19%, compared to NBR's ROE of +0.58%. Regarding short-term risk, ICD is more volatile compared to NBR. This indicates potentially higher risk in terms of short-term price fluctuations for ICD.Check NBR's competition here

ICD plays a significant role within the Energy sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICD stands at 8.9M. In comparison, PDS has a market cap of 1.2B. Regarding current trading prices, ICD is priced at $0.59, while PDS trades at $92.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICD currently has a P/E ratio of -0.14, whereas PDS's P/E ratio is 920.30. In terms of profitability, ICD's ROE is -0.19%, compared to PDS's ROE of +0.00%. Regarding short-term risk, ICD is more volatile compared to PDS. This indicates potentially higher risk in terms of short-term price fluctuations for ICD.Check PDS's competition here

ICD plays a significant role within the Energy sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICD stands at 8.9M. In comparison, PRB has a market cap of 49. Regarding current trading prices, ICD is priced at $0.59, while PRB trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICD currently has a P/E ratio of -0.14, whereas PRB's P/E ratio is N/A. In terms of profitability, ICD's ROE is -0.19%, compared to PRB's ROE of N/A. Regarding short-term risk, ICD is less volatile compared to PRB. This indicates potentially lower risk in terms of short-term price fluctuations for ICD.Check PRB's competition here

ICD plays a significant role within the Energy sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICD stands at 8.9M. In comparison, ATW has a market cap of 0. Regarding current trading prices, ICD is priced at $0.59, while ATW trades at $470.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICD currently has a P/E ratio of -0.14, whereas ATW's P/E ratio is N/A. In terms of profitability, ICD's ROE is -0.19%, compared to ATW's ROE of +0.09%. Regarding short-term risk, ICD is more volatile compared to ATW. This indicates potentially higher risk in terms of short-term price fluctuations for ICD.Check ATW's competition here

ICD plays a significant role within the Energy sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ICD stands at 8.9M. In comparison, ORIG has a market cap of 0. Regarding current trading prices, ICD is priced at $0.59, while ORIG trades at $27.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ICD currently has a P/E ratio of -0.14, whereas ORIG's P/E ratio is N/A. In terms of profitability, ICD's ROE is -0.19%, compared to ORIG's ROE of -0.00%. Regarding short-term risk, ICD is more volatile compared to ORIG. This indicates potentially higher risk in terms of short-term price fluctuations for ICD.Check ORIG's competition here